228 related articles for article (PubMed ID: 32670354)
1. Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
Liu Z; Lin Y; Gao X; Mai R; Piao X; Ye J; Liang R
Front Genet; 2020; 11():634. PubMed ID: 32670354
[No Abstract] [Full Text] [Related]
2. Systems biology based meth-miRNA-mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progression.
Zahid KR; Su M; Khan ARR; Han S; Deming G; Raza U
Cancer Cell Int; 2019; 19():89. PubMed ID: 31007607
[TBL] [Abstract][Full Text] [Related]
3. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
[No Abstract] [Full Text] [Related]
4. Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma.
Bian J; Long J; Yang X; Yang X; Xu Y; Lu X; Guan M; Sang X; Zhao H
Ann Transl Med; 2021 May; 9(9):765. PubMed ID: 34268378
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
6. Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma.
Wu Q; Wang L; Tsui SK
Front Genet; 2022; 13():970907. PubMed ID: 36081995
[TBL] [Abstract][Full Text] [Related]
7. Integrative multiomics evaluation reveals the importance of pseudouridine synthases in hepatocellular carcinoma.
Jin Z; Song M; Wang J; Zhu W; Sun D; Liu H; Shi G
Front Genet; 2022; 13():944681. PubMed ID: 36437949
[No Abstract] [Full Text] [Related]
8. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
10. Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma.
Front Mol Biosci; ; . PubMed ID: 34124163
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
